Urothelial Cancers
Here below, you will find a list of all the latest content published on this website on the topic of Urothelial Cancers. The content is published in chronological order. Find out more about our content categorisation.
-
« Previous
- 1
- 2
- ...
- 10
-
Next »
- 9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers
- Evaluation of topoisomerase II, Ki-67 and P53 expression in non-muscle invasive urothelial carcinoma and their clinical significance
- Expression of HER2-neu, SKP2 and HIF-1 and their role in predicting the response of muscle invasive urothelial carcinoma to bladder- preservation c...
- Neoadjuvant Dose-Dense MVAC May Improve Bladder Cancer Outcomes
- ESMO E-Learning: Urothelial Cell Cancer
- Bladder and Renal Cell Cancer
- Introduction
- Case presentation: Second-line treatment for bladder cancer
- Advanced Urinary Cancer (Renal and Bladder)
- Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
- Gastric and colorectal
- Bladder cancer
- Molecular sub-types and implications for prognosis and therapy
- Lymph node dissection: How high is enough?
- Bladder preservation: How and for whom?
- JAVELIN Points To Further Avelumab Investigation For Metastatic Urothelial Carcinoma
- PD-L1 in Cancer: ESMO Biomarker Factsheet
- Adjuvant Chemotherapy Plus Radiotherapy Benefits Reported For Locally Advanced Bladder Cancer
- GU (prostate, bladder)
- Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study (272O)
- MECA79 positive high endothelial venule density (HEV) correlates with clinical outcomes in Upper Tract Urothelial Carcinoma patients treated with R...
- The Evaluation and Outcome of A New Intravesical BCG Protocol For Non-muscle Invasive Bladder Cancer In A Tertiary Care Center In India (280P)
- S-1 plus cisplatin combination therapy in patients with urachal carcinoma; a retrospective study (282P)
- High-throughput proteome identifies ANHAK as a novel biomarker for bladder urothelial carcinoma diagnosis in liquid-based cytology. (27P)
- Intravesicle therapy in early bladder cancer: immunotherapy to the fore again
-
« Previous
- 1
- 2
- ...
- 10
-
Next »